ArticleMedicine and pharmacy reports2021

Study of ischemia modified albumin (IMA) as a biomarker in hypertensive retinopathy.

Ecaterina Pavlovschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.